SCIENTIST TO WATCH

Matthew Albert: Fascinated by Cell Death

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Matthew Albert passes a bust of Ilya Mechnikov every day on the way to his office at the Institute Pasteur in Paris. Working in the same building as the man who discovered phagocytosis is "humbling," he says, but the young immunologist shares with the 1908 Nobel Prize winner a fascination with cell death and a fixation on how science can improve the human condition.

As a crystallographer at Brown University, Albert worked on technologies to convert sunlight to electricity. When Raytheon, the developer of Patriot missiles, appropriated the project, Albert decided that a change was in order. "If there was going to be an application for my work, I wanted to be a bit more confident that at the other end someone was benefiting in terms of quality of life." He started an MD/PhD program in immunology at Rockefeller University and Cornell Medical College in New York in 1993.

Under ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Aude Lecrubier

    This person does not yet have a bio.

Published In

Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development